Archive: 16/11/2015

A new target for immuno-oncology therapies

By studying a type of immune cells, a team of researchers at the IRCM led by André Veillette, MD, identified the mechanism of action for a new target for novel immune-oncology treatments. Their discovery is published today ...

page 2 from 8